- Home
- XOMA vs NAUT Comparison
XOMA vs NAUT Comparison
Compare XOMA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XOMA | NAUT |
|---|---|---|
| Founded | 1981 | 2016 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.6M | 383.5M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | XOMA | NAUT |
|---|---|---|
| Price | $41.56 | $2.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $67.00 | $4.00 |
| AVG Volume (30 Days) | 272.3K | ★ 295.9K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.59 | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | $29.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.29 | $0.62 |
| 52 Week High | $42.81 | $4.31 |
Technical Indicators
Market Signals| Indicator | XOMA | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 71.23 | 39.60 |
| Support Level | $24.38 | $1.82 |
| Resistance Level | N/A | $3.18 |
| Average True Range (ATR) | 1.58 | 0.25 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 76.97 | 14.64 |
Price Performance
Historical ComparisonAbout XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.